1. Metformin-induced protection against oxidative stress is associated with AKT/mTOR restoration in PC12 cells
   Behzad Khallaghi et al, 2016, Life Sciences CrossRef
2. A Metabolic Inhibitory Cocktail for Grave Cancers: Metformin, Pioglitazone and Lithium Combination in Treatment of Pancreatic Cancer and Glioblastoma Multiforme
   İlhan Elmaci et al, 2016, Biochemical Genetics CrossRef
3. Metformin‑induced apoptosis facilitates degradation of the cellular caspase 8 (FLICE)‑like inhibitory protein through a caspase‑dependent pathway in human renal cell carcinoma A498 cells
   Ji‑Hoon Jang et al, 2018, Oncology Letters CrossRef
4. Metformin Treatment Inhibits Motility and Invasion of Glioblastoma Cancer Cells
   Marwa Al Hassan et al, 2018, Analytical Cellular Pathology CrossRef
5. Targeted Therapy for Malignant Brain Tumors
   Paula Lam et al, 2016, Redox-Active Therapeutics CrossRef
6. A novel biguanide (IM1761065) inhibits bioenergetics of glioblastoma tumorspheres
   Tae Hoon Roh et al, 2022, Journal of Neuro-Oncology CrossRef
7. The Potential Therapeutic Impact of Metformin in Glioblastoma Multiforme
   Mehdi Sanati et al, 2023, Current Medicinal Chemistry CrossRef
8. Metformin Inhibits Growth of Human Glioblastoma Cells and Enhances Therapeutic Response
   Julie Sesen et al, 2015, PLOS ONE CrossRef
9. Phenyl-guanidine derivatives as potential therapeutic agents for glioblastoma multiforme: catalytic syntheses, cytotoxic effects and DNA affinity
   I. Bravo et al, 2016, RSC Advances CrossRef
10. Drug Repositioning in Glioblastoma: A Pathway Perspective
    Sze Kiat Tan et al, 2018, Frontiers in Pharmacology CrossRef